Doug Schenkel
Stock Analyst at UBS
(4.94)
# 154
Out of 5,081 analysts
415
Total ratings
66%
Success rate
26.6%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DHR Danaher | Reiterated: Buy | $250 → $260 | $232.97 | +11.60% | 25 | Oct 22, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $730 → $800 | $684.89 | +16.81% | 23 | Oct 22, 2026 | |
| A Agilent Technologies | Reiterated: Hold | $180 | $175.96 | +2.30% | 35 | Oct 14, 2026 | |
| GRAL GRAIL | Reiterated: Buy | $105 → $175 | $139.91 | +25.08% | 4 | Oct 2, 2026 | |
| RGEN Repligen | Reiterated: Buy | $225 | $180.17 | +24.88% | 4 | Sep 29, 2026 | |
| LON: VTY Vistry Group PLC | Initiated Coverage: Hold | 300p | 255p | +17.55% | 1 | Sep 9, 2026 | |
| GH Guardant Health | Reiterated: Buy | $75 → $225 | $173.25 | +29.87% | 9 | Sep 9, 2026 | |
| ILMN Illumina | Upgraded: Buy | $150 → $260 | $271.04 | -4.07% | 40 | Sep 9, 2026 | |
| NTRA Natera | Reiterated: Buy | $135 → $435 | $404.90 | +7.43% | 18 | Sep 9, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $50 → $65 | $48.20 | +34.85% | 2 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $480 → $490 | $455.98 | +7.46% | 23 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $415 | $394.73 | +5.14% | 2 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $58.23 | +3.04% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $17.29 | n/a | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $32.46 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.02 | n/a | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1,669.62 | n/a | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $19.88 | n/a | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $67.16 | n/a | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $145.25 | n/a | 4 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €265.00 | €289.50 | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $7.58 | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $50.37 | n/a | 25 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $72.96 | n/a | 9 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $2.25 | n/a | 6 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $160.39 | n/a | 25 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $7.52 | n/a | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $9.45 | n/a | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.04 | n/a | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | - | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $25 | $1.30 | n/a | 7 | Jul 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $26 | $7.47 | n/a | 5 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.65 | n/a | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.93 | n/a | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $540 | $78.57 | n/a | 25 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $11.15 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $90 | $18.90 | n/a | 18 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $4 | $0.60 | n/a | 14 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $26.27 | n/a | 1 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $15.88 | n/a | 1 | Jul 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $149.26 | n/a | 15 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $275 | $196.39 | n/a | 12 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.83 | n/a | 1 | Jan 2, 2018 |
Danaher
Oct 22, 2026
Reiterated: Buy
Price Target: $250 → $260
Current: $232.97
Upside: +11.60%
Thermo Fisher Scientific
Oct 22, 2026
Reiterated: Buy
Price Target: $730 → $800
Current: $684.89
Upside: +16.81%
Agilent Technologies
Oct 14, 2026
Reiterated: Hold
Price Target: $180
Current: $175.96
Upside: +2.30%
GRAIL
Oct 2, 2026
Reiterated: Buy
Price Target: $105 → $175
Current: $139.91
Upside: +25.08%
Repligen
Sep 29, 2026
Reiterated: Buy
Price Target: $225
Current: $180.17
Upside: +24.88%
Vistry Group PLC
Sep 9, 2026
Initiated Coverage: Hold
Price Target: 300p
Current: 255p
Upside: +17.55%
Guardant Health
Sep 9, 2026
Reiterated: Buy
Price Target: $75 → $225
Current: $173.25
Upside: +29.87%
Illumina
Sep 9, 2026
Upgraded: Buy
Price Target: $150 → $260
Current: $271.04
Upside: -4.07%
Natera
Sep 9, 2026
Reiterated: Buy
Price Target: $135 → $435
Current: $404.90
Upside: +7.43%
Veracyte
Sep 9, 2026
Reiterated: Buy
Price Target: $50 → $65
Current: $48.20
Upside: +34.85%
Sep 9, 2026
Upgraded: Buy
Price Target: $480 → $490
Current: $455.98
Upside: +7.46%
Sep 9, 2026
Reiterated: Buy
Price Target: $415
Current: $394.73
Upside: +5.14%
Dec 10, 2025
Upgraded: Buy
Price Target: $60
Current: $58.23
Upside: +3.04%
Jul 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $17.29
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $32.46
Upside: n/a
May 7, 2025
Downgraded: Hold
Price Target: n/a
Current: $6.02
Upside: n/a
Dec 13, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $1,669.62
Upside: n/a
Dec 13, 2024
Initiated Coverage: Buy
Price Target: $28
Current: $19.88
Upside: n/a
Dec 13, 2024
Initiated Coverage: Buy
Price Target: $60
Current: $67.16
Upside: n/a
Dec 13, 2024
Initiated Coverage: Buy
Price Target: $60
Current: $145.25
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: €265.00
Current: €289.50
Upside: n/a
Nov 14, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $7.58
Upside: n/a
Jun 27, 2024
Upgraded: Buy
Price Target: $50
Current: $50.37
Upside: n/a
Jun 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $72.96
Upside: n/a
Dec 12, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $2.25
Upside: n/a
Dec 12, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $160.39
Upside: n/a
Aug 17, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $7.52
Upside: n/a
Aug 16, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $9.45
Upside: n/a
Aug 9, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $2.04
Upside: n/a
Aug 4, 2021
Downgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Jul 1, 2021
Reiterated: Buy
Price Target: $18 → $25
Current: $1.30
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $17 → $26
Current: $7.47
Upside: n/a
Jan 12, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $11.65
Upside: n/a
Dec 29, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $1.93
Upside: n/a
Sep 28, 2020
Reiterated: Buy
Price Target: $540
Current: $78.57
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $11.15
Upside: n/a
Feb 25, 2020
Reiterated: Buy
Price Target: $85 → $90
Current: $18.90
Upside: n/a
Jan 6, 2020
Reiterated: Hold
Price Target: $10 → $4
Current: $0.60
Upside: n/a
Jul 22, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $26.27
Upside: n/a
Jul 15, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $15.88
Upside: n/a
Mar 20, 2019
Reiterated: Buy
Price Target: $110
Current: $149.26
Upside: n/a
Aug 2, 2018
Reiterated: Buy
Price Target: $250 → $275
Current: $196.39
Upside: n/a
Jan 2, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $2.83
Upside: n/a